InvestorsHub Logo

thefamilyman

09/17/16 9:59 AM

#6319 RE: aravali #6318

Unfortunately, I have to agree with your assessment. The terms of that last funding really pissed me off. I have been trying to console myself that the most recent funding would be the last before results come in from the Parkinson's trial in Australia. But that news article says that those results will not be in for two years.

As an investor in this company, this is great news, but the management seem more interested in taking a constant stream of stock options and undertaking private placings at huge discounts to friends and family (at the expense of existing shareholders) than actually getting on with the work at hand - aravali

Doctor_Hari_Seldon

09/23/16 6:56 PM

#6320 RE: aravali #6318

I am not so sure about that. I have been invested here for a long time and have endured extreme dilution. I am not sure I will ever get my original investment back. HOWEVER...... To me it looks more like the principle is buying just enough new stock to keep things funded on an as needed basis, in lieu of getting involved with too many costly stock offerings that usually bring the true significant dilution (which I have experienced here).

This company, while precariously operating on thin finances has done almost everything they said they would do over the many years I have been invested.

The second patient is due to undergo surgery soon. Reference:
http://www.adelaidenow.com.au/lifestyle/health/adelaide-businessman-kevin-weeks-to-be-treated-with-dopamineproducing-stem-cells-in-a-worldfirst-medical-trial-for-parkinsons-disease/news-story/187d060ba1a6945779afcae923ea3653

Best regards and wishing all the best of good buys.

HS